The introduction of nicotinamide being a nicotine substitution in e-cigarette and smokeless solutions signifies a big regulatory challenge for the FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to work as a sedative at substantial dosages6. The promises produced by Nicotine River, ECBlend, and other vendors that th